Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2015, Article ID 513602, 8 pages
http://dx.doi.org/10.1155/2015/513602
Case Report

Atypical Endobronchial Carcinoid with Postobstructive Pneumonia Obscuring the Diagnosis of Granulomatosis with Polyangiitis

1Department of Internal Medicine, University of Florida, Jacksonville, USA
2Department of Pathology, University of Florida, Jacksonville, USA

Received 31 May 2015; Accepted 29 July 2015

Academic Editor: Toshiaki Takahashi

Copyright © 2015 Robert Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. K. Lutalo and D. P. D'Cruz, “Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis),” Journal of Autoimmunity, vol. 48-49, pp. 94–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. G. Sott and R. A. Watts, “Systemic vasculitis: epidemiology, classification and environmental factors,” Annals of the Rheumatic Diseases, vol. 59, no. 3, Article ID 161e3, 2000. View at Google Scholar
  3. S. E. Lane, R. Watts, and D. G. Scott, “Epidemiology of systemic vasculitis,” Current Rheumatology Reports, vol. 7, no. 4, pp. 270–275, 2005. View at Publisher · View at Google Scholar
  4. R. Cartin-Ceba, T. Peikert, and U. Specks, “Pathogenesis of ANCA-associated vasculitis,” Current Rheumatology Reports, vol. 14, no. 6, pp. 481–493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mueller, K. Holl-Ulrich, P. Lamprecht, and W. L. Gross, “Germinal centre-like structures in Wegener's granuloma: the morphological basis for autoimmunity?” Rheumatology, vol. 47, no. 8, pp. 1111–1113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. S. Fauci, S. M. Wolff, and J. S. Johnson, “Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis,” The New England Journal of Medicine, vol. 285, no. 27, pp. 1493–1496, 1971. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Lockwood, A. J. Pinching, P. Sweny et al., “Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis,” The Lancet, vol. 309, no. 8002, pp. 63–67, 1977. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Stone, P. A. Merkel, R. Spiera et al., “Rituximab versus cyclophosphamide for ANCA-associated vasculitis,” The New England Journal of Medicine, vol. 363, no. 3, pp. 221–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. B. Jones, J. W. C. Tervaert, T. Hauser et al., “Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis,” The New England Journal of Medicine, vol. 363, no. 3, pp. 211–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Ananthakrishnan, N. Sharma, and J. P. Kanne, “Wegener's granulomatosis in the chest: high resolution CT findings,” American Journal of Roentgenology, vol. 192, no. 3, pp. 676–682, 2009. View at Publisher · View at Google Scholar
  11. S. K. Frankel, G. P. Cosgrove, A. Fischer, R. T. Meehan, and K. K. Brown, “Update in the diagnosis and management of pulmonary vasculitis,” Chest, vol. 129, no. 2, pp. 452–465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Guneyli, N. Ceylan, S. Bayraktaroglu et al., “Imaging findings of pulmonary granulomatosis with polyangiitis (Wegener’s granulomatosis): lesions invading the pulmonary fissure, pleura or diaphragm mimicking malignancy,” Wiener klinische Wochenschrift, 2015. View at Publisher · View at Google Scholar
  13. C. Lohrmann, M. Uhl, E. Kotter, D. Burger, N. Ghanem, and M. Langer, “Pulmonary manifestations of wegener granulomatosis: CT findings in 57 patients and a review of the literature,” European Journal of Radiology, vol. 53, no. 3, pp. 471–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Mehta and M. Cutaia, “The role of interventional pulmonary procedures in the management of post-obstructive pneumonia,” Current Infectious Disease Reports, vol. 8, no. 3, pp. 207–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Simoff, “Endobronchial management of advanced lung cancer,” Cancer Control, vol. 8, no. 4, pp. 337–343, 2001. View at Google Scholar · View at Scopus
  16. S. Cavaliere, P. Foccoli, and P. L. Farina, “Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients,” Chest, vol. 94, no. 1, pp. 15–21, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. T. J. M. van Boxem, J. Westerga, B. J. W. Venmans, P. E. Postmus, and T. G. Sutedja, “Tissue effects of bronchoscopic electrocautery: bronchoscopic appearance and histologic changes of bronchial wall after electrocautery,” Chest, vol. 117, no. 3, pp. 887–891, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. R. C. Morice, T. Ece, F. Ece, and L. Keus, “Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction,” Chest, vol. 119, no. 3, pp. 781–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kato, T. Okunaka, and H. Shimatani, “Photodynamic therapy for early stage bronchogenic carcinoma,” Journal of Clinical Laser Medicine and Surgery, vol. 14, no. 5, pp. 235–238, 1996. View at Google Scholar · View at Scopus
  20. A. Marasso, E. Gallo, G. M. Massaglia, M. Onoscuri, and V. Bernardi, “Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis: indications, limits, personal experience,” Chest, vol. 103, no. 2, pp. 472–474, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Hautmann, F. Gamarra, K. J. Pfeifer, and R. M. Huber, “Fiberoptic bronchoscopic balloon dilatation in malignant tracheobronchial disease indications and results,” Chest, vol. 120, no. 1, pp. 43–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Miyazawa, M. Yamakido, S. Ikeda et al., “Implantation of ultraflex nitinol stents in malignant tracheobronchial stenoses,” Chest, vol. 118, no. 4, pp. 959–965, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Attali, R. Begum, H. Romdhane, D. Valeyre, L. Guillevin, and M. W. Brauner, “Pulmonary Wegener's granulomatosis: changes at follow-up CT,” European Radiology, vol. 8, no. 6, pp. 1009–1113, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. R. E. Sheehan, J. D. A. Flint, and N. L. Müller, “Computed tomography features of the thoracic manifestations of Wegener granulomatosis,” Journal of Thoracic Imaging, vol. 18, no. 1, pp. 34–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. E. J. Mark, D. B. Flieder, and O. Matsubara, “Treated Wegener's granulomatosis: distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease,” Human Pathology, vol. 28, no. 4, pp. 450–458, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. E. W. Walton, “Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis),” British Medical Journal, vol. 2, no. 5091, pp. 265–270, 1958. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Jayne, “Review article: progress of treatment in ANCA-associated vasculitis,” Nephrology, vol. 14, no. 1, pp. 42–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. de Groot, L. Harper, D. R. W. Jayne et al., “Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial,” Annals of Internal Medicine, vol. 150, no. 10, pp. 670–680, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. S. Hoffman, R. Y. Leavitt, G. S. Kerr, and A. S. Fauci, “The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate,” Arthritis & Rheumatism, vol. 35, no. 11, pp. 1322–1329, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. K. De Groot, N. Rasmussen, P. A. Bacon et al., “Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis,” Arthritis & Rheumatism, vol. 52, no. 8, pp. 2461–2469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Faurschou, K. Westman, N. Rasmussen et al., “Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis,” Arthritis and Rheumatism, vol. 64, no. 10, pp. 3472–3477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Jayne, N. Rasmussen, K. Andrassy et al., “A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies,” The New England Journal of Medicine, vol. 349, no. 1, pp. 36–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Ribi, P. Cohen, C. Pagnoux et al., “Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 586–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. G. J. Weiner, “Rituximab: mechanism of action,” Seminars in Hematology, vol. 47, no. 2, pp. 115–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Lowndes, A. Darby, G. Mead, and A. Lister, “Stevens-Johnson syndrome after treatment with rituximab,” Annals of Oncology, vol. 13, no. 12, pp. 1948–1950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Sagnelli, M. Pisaturo, C. Sagnelli, and N. Coppola, “Rituximab-based treatment, HCV replication, and hepatic flares,” Clinical and Developmental Immunology, vol. 2012, Article ID 945950, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-H. Wang, L. Fan, L. Wang et al., “Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy,” Supportive Care in Cancer, vol. 21, no. 5, pp. 1265–1271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Klemmer, W. Chalermskulrat, M. S. Reif, S. L. Hogan, D. C. Henke, and R. J. Falk, “Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis,” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1149–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. C. D. Pusey, A. J. Rees, D. J. Evans, D. K. Peters, and C. M. Lockwood, “Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies,” Kidney International, vol. 40, no. 4, pp. 757–763, 1991. View at Publisher · View at Google Scholar · View at Scopus
  40. D. R. W. Jayne, G. Gaskin, N. Rasmussen et al., “Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,” Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2180–2188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Alberici and D. R. W. Jayne, “Impact of rituximab trials on the treatment of ANCA-associated vasculitis,” Nephrology Dialysis Transplantation, vol. 29, no. 6, pp. 1151–1159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-S. F. Sanders, M. G. Huitma, C. G. M. Kallenberg, and C. A. Stegeman, “Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment,” Rheumatology, vol. 45, no. 6, pp. 724–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Martinez, P. Cohen, C. Pagnoux et al., “Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients,” Arthritis & Rheumatism, vol. 58, no. 1, pp. 308–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Talar-Williams, Y. M. Hijazi, M. McClellan et al., “Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis,” Annals of Internal Medicine, vol. 124, no. 5, pp. 477–484, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Knight, J. Askling, and A. Ekbom, “Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis,” International Journal of Cancer, vol. 100, no. 1, pp. 82–85, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Fain, M. Hamidou, P. Cacoub et al., “Vasculitides associated with malignancies: analysis of sixty patients,” Arthritis Care & Research, vol. 57, no. 8, pp. 1473–1480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Faurschou, L. Mellemkjaer, A. Voss, K. K. Keller, I. T. Hansen, and B. Baslund, “Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis,” Rheumatology, vol. 54, no. 8, pp. 1345–1350, 2015. View at Publisher · View at Google Scholar
  48. J. Stein, S. T. Sridharan, I. Eliachar, A. Niv, B. Wood, and G. S. Hoffman, “Nasal cavity squamous cell carcinoma in Wegener's granulomatosis,” Archives of Otolaryngology—Head and Neck Surgery, vol. 127, no. 6, pp. 709–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Villa-Forte and G. S. Hoffman, “Wegener's granulomatosis presenting with a renal mass,” Journal of Rheumatology, vol. 26, no. 2, pp. 457–458, 1999. View at Google Scholar · View at Scopus
  50. J. C. Yao, M. Hassan, A. Phan et al., “One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States,” Journal of Clinical Oncology, vol. 26, no. 18, pp. 3063–3072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Öberg, P. Hellman, D. Kwekkeboom, and S. Jelic, “Neuroendocrine bronchial and thymic tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 21, supplement 5, pp. v220–v222, 2010. View at Publisher · View at Google Scholar
  52. A. Naalsund, H. Rostad, E. H. Strøm, M. B. Lund, and T.-E. Strand, “Carcinoid lung tumors - incidence, treatment and outcomes: a population-based study,” European Journal of Cardio-thoracic Surgery, vol. 39, no. 4, pp. 565–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. W. D. Travis, R. I. Linnoila, M. G. Tsokos et al., “Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases,” The American Journal of Surgical Pathology, vol. 15, no. 6, pp. 529–553, 1991. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Tsuta, M. G. Raso, N. Kalhor, D. D. Liu, I. I. Wistuba, and C. A. Moran, “Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung,” Lung Cancer, vol. 71, no. 1, pp. 34–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. C. F. Thomas Jr., H. D. Tazelaar, and J. R. Jett, “Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement,” Chest, vol. 119, no. 4, pp. 1143–1150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. M. G. Arrigoni, L. B. Woolner, and P. E. Bernatz, “Atypical carcinoid tumors of the lung,” The Journal of Thoracic and Cardiovascular Surgery, vol. 64, no. 3, pp. 413–421, 1972. View at Google Scholar · View at Scopus
  57. R. Hage, A. B. de la Rivière, C. A. Seldenrijk, and J. M. M. van den Bosch, “Update in pulmonary carcinoid tumors: a review article,” Annals of Surgical Oncology, vol. 10, no. 6, pp. 697–704, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. García-Yuste, J. M. Matilla, A. Cueto et al., “Typical and atypical carcinoid tumours: analysis of the experience of the Spanish multi-centric study of neuroendocrine tumours of the lung,” European Journal of Cardio-Thoracic Surgery, vol. 31, no. 2, pp. 192–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. Lung NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, Version 2, 2012.